Model
Edge
Jazz Pharmaceuticals
JAZZ
Filing type
10-Q
Filing date
Aug 5, 2025
Updated
Aug 6, 2025 ยท 5:33 AM
Copy reference
Filing
10-Q
Q2
Exhibits
EX-10.1A
LICENSE AND OPTION AGREEMENT
EX-10.1B
AMENDED AND RESTATED LICENSE AND OPTION AGREEMENT
EX-10.2
LETTER AGREEMENT
EX-31.1
CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
EX-31.2
CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
EX-32.1
CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350
GRAPHIC
Graphic
GRAPHIC
Graphic